{"schema_version":"secwatch.filing_event.v1","accession":"0001835378-24-000052","form_type":"8-K","ticker":null,"cik":"0001835378","company_name":"Innovid Corp.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.587629+00:00","generated_at":"2026-06-02T19:58:28.259220+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Innovid Q1 revenue $36.7M (+21% YoY), net loss narrows, EBITDA positive; raises FY guidance","bullets":["Q1 revenue $36.7M, up 21% YoY; net loss improved to $6.2M from $8.6M.","Adjusted EBITDA $4.4M (12% margin) vs $0.1M; free cash flow $2.0M vs -$2.8M.","FY 2024 revenue guidance raised to $156M-$163M; FY Adj. EBITDA guidance raised to $24M-$29M.","Q2 2024 revenue expected $37.5M-$39.5M (9-14% YoY growth); Adj. EBITDA $5.0M-$6.0M.","New client wins include Eli Lilly, Verizon; launched Harmony Direct supply-path optimization."],"urls":{"canonical":"https://secwatch.observer/filing/0001835378-24-000052","json":"https://secwatch.observer/filing/0001835378-24-000052.json","markdown":"https://secwatch.observer/filing/0001835378-24-000052.md","text":"https://secwatch.observer/filing/0001835378-24-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835378/000183537824000052/0001835378-24-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835378/000183537824000052/ctv-20240507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:58:28.259220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c8e66dac4c961275ee630addc978d650a2bde68","claim":"Innovid Corp. reported the quarter ended March 31, 2024 results: revenue $36.7 million, net income net loss was $6.2 million.","evidence_excerpt":"in such filing. --- EX-99.1 (EX-99.1) --- Innovid Reports Q1 2024 Financial Results • Company exceeds both revenue and Adjusted EBITDA guidance for Q1 • Q1 revenue grew to $36.7 million, up 21% year-over-year • Q1 net loss improved year-over-year to $6.2 million and Adjusted EBITDA* improved to $4.4 million, representing a 12% Adjusted EBITDA margin* • Company","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1835378/000183537824000052/0001835378-24-000052-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$36.7 million"},{"label":"Net income","value":"net loss was $6.2 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}